Part number 100-236-400 for standard pacbio service contract with base plus four options
Ended Purchase Order Awarded Last action
- Contract number
- HHSF223201510421A
- Awardee
-
Pacific Biosciences Of California, Inc. UEI CP22V46XYQK6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $336,000
Award facts
- Contract value 100% obligated
- $336,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Exercise an Option | $84,000 | |
| Exercise an Option | $84,000 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $84,000 | |
| Original award | $84,000 |
About this award
The Food and Drug Administration (FDA) awarded a $336,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. on August 21, 2015, for Part Number 100-236-400, a standard PacBio service contract with a base period and four option years. The contract was completed on July 22, 2019, with performance undertaken at the contractor's facility in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences is a leading biotechnology company specializing in long-read DNA and RNA sequencing technologies, providing advanced genomic analysis systems and reagents to federal research agencies.
This procurement supported the FDA's scientific research and regulatory capabilities through access to Pacific Biosciences' specialized sequencing services and technology. The award demonstrates the agency's reliance on commercial sequencing solutions for genomic analysis work that supports FDA missions in areas such as biotechnology oversight and regulatory science. The contract structure with options provided flexibility to extend the service relationship based on the FDA's ongoing research needs. This award predates Pacific Biosciences' later establishment of two significant Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicles with the USDA and FDA, which further solidified the company's role as a key supplier of genomic sequencing capabilities across federal agencies.
Quick answers
Who was awarded contract HHSF223201510421A?
HHSF223201510421A was awarded to Pacific Biosciences Of California, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 21, 2015.
How much is contract HHSF223201510421A worth?
The government has obligated $336,000 on HHSF223201510421A.
Was contract HHSF223201510421A competed?
The extent of competition for HHSF223201510421A was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award